. The effect of 3TC 5'-triphosphate on both the RNA-dependent and DNA-dependent activities of human immunodeficiency virus type 1 reverse transcriptase and DNA polymerases alpha, beta, and gamma from HeLa cells was investigated. 3TC 5'-triphosphate is a competitive inhibitor (with respect to dCTP) of the RNA-dependent DNA polymerase activity (apparent Ki = 10.6 1.0 to 12.4 5.1 ,uM, depending on the template and primer used); the DNA-dependent DNA polymerase activity is 50%o inhibited by a 3TC 5'-triphosphate concentration of 23.4 + 2.5 ,uM when dCTP is present at a concentration equal to its Km value. Chain elongation studies show that 3TC 5'-triphosphate is incorporated into newly synthesized DNA and that transcription is terminated in a manner identical to that found for ddCTP. The 50%o inhibitory concentrations of 3TC 5'-triphosphate against DNA polymerases alpha, beta, and gamma at concentrations of dCTP equal to the Km were 175 31, 24.8 10.9, and 43.8 16.4 ,uM, respectively. More detailed kinetic studies with 3TC 5'-triphosphate and DNA polymerases beta and gamma are consistent with the fact that inhibition of these enzymes by 3TC 5'-triphosphate is competitive with respect to dCTP. The values of Ki were determined to be 18.7 ,uM for DNA polymerase beta and 15.8 0.8 ,uM for DNA polymerase gamma.
polymerase beta and 15.8 0.8 ,uM for DNA polymerase gamma.
The (-)-enantiomer of 2'-deoxy-3'-thiacytidine (also known as 3TC; Fig. 1 ) is an effective inhibitor of human immunodeficiency virus (HIV) replication (6) that has now entered clinical trials. Related 2,3'-dideoxynucleosides, e.g., dideoxycytidine (ddC) and 3'-azido-3'-deoxythymidine (AZT), have been shown to be effective against HIV because they can be phosphorylated to the corresponding 5'-triphosphates, which act both as competitive inhibitors of the viral reverse transcriptase (EC 2.7.7.49) and as chain terminators (12, 15, 20) , preventing further elongation of the oligonucleotide chain. Because 3TC has been shown to be phosphorylated within HIV type 1 (HIV-1)-infected cells (3), we investigated the effect of the corresponding 5'-triphosphate on HIV-1 reverse transcriptase and DNA polymerases alpha, beta, and gamma, the three mammalian DNA-dependent DNA polymerases (EC 2.7.7.7) that have been investigated in the greatest detail. The effect of 3TC 5'-triphosphate on DNA polymerase gamma is particularly relevant, because it has been suggested that inhibition of this enzyme may be linked to the peripheral neuropathy observed in some patients treated with ddC or dideoxyinosine (ddI) (4, 5) .
The effect of 3TC 5'-triphosphate on these enzymes is reported and is compared, under the same conditions, with the activities of racemic 2'-deoxy-3'-thiacytidine 5'-triphosphate (also known as BCH 189 5'-triphosphate), the (+)-enantiomer of the same compound, ddATP, ddCTP, and AZT 5'-triphosphate. ddATP, ddCTP, and AZT 5'-triphosphate were chosen for comparison because they are thought to be the forms of the anti-HIV compounds ddl, ddC, and AZT that are active against the viral reverse transcriptase (1, 13) . We also report on the ability of 3TC 5'-triphosphate to act as a chain terminator of DNA synthesis catalyzed by HIV-1 reverse transcriptase.
MATERIALS AND METHODS
Abbreviations used. The abbreviations and trivial names used in this report are as follows: 3TC, (-)-2'-deoxy-3'-thiacytidine; BCH 189, (+)-2'-deoxy-3'-thiacytidine; HIV, human immunodeficiency virus; dNTPs, 2'-deoxynucleoside 5'-triphosphates; ddNTPs, 2',3'-dideoxynucleoside 5'-triphosphates; AZT, 3'-deoxy-3'-azidothymidine; ddATP, 2',3'-dideoxyadenosine 5'-triphosphate; ddC, 2',3'-dideoxycytidine; ddCTP, 2',3'-dideoxycytidine 5'-triphosphate; ddGTP, 2',3'-dideoxyguanosine 5'-triphosphate; ddI, 2',3'-dideoxyinosine; ddTTP, 2',3'-dideoxythymidine 5 Preparation of activated calf thymus DNA. Activated calf thymus DNA was prepared essentially as described previously (2). It was then dialyzed against 0.01 M KCl and stored at -20°C until it was required.
Determination of nucleotide concentrations. The concentrations of stock solutions of nucleotides were determined from their absorbances at Xm. by using the values for molar absorption coefficients given by Dawson et al. (8) . The concentrations of the 2'-deoxy-3'-thiacytidine 5'-triphosphates were determined at pH 7.0 by using an P272 value of 9.1 x 103 liter mol-1 cm-1. This is the value given previously (8) removed at intervals over the first 20 to 30 min of the reaction and were spotted onto a DEAE filter mat that was previously soaked in 0.1 M tetrasodium EDTA and air dried. The filter mat was washed, and the radioactivity was counted as described above.
(v) DNA polymerase gamma. During its purification, DNA polymerase gamma was assayed in 50 mM Tris-HCI buffer (pH 8.5) containing 0.5 mg of bovine serum albumin ml-1, 50 mM KCl, 0.5 mM dithiothreitol or 1.67 mM 2-mercaptoethanol, 0.5 mM MnCl2 or 6.5 mM MgCI2, 0.1 mg of poly(rA) poly(dT)12-18 ml-', and 1 p.M dTTP (containing 1 ,uCi of 3H per 50-,ul assay). Assay solutions, which contained 10 pI of enzyme solution, were incubated at 37°C for 45 min, and then 25-pI samples were removed and spotted onto a DEAE filter mat that was previously soaked in 0.1 M tetrasodium EDTA and air dried. The filter mat was washed, and the radioactivity was counted as described above.
For most of the detailed kinetic studies with DNA polymerase gamma, assays were carried out at 37°C in 75 mM For detailed kinetic studies, the assay solutions (total volume, 0.2 ml) were the same as those described above, except that 20 ,ul of enzyme solution was used per assay and the three nonlabeled dNTPs were each present at 83 P,M, with the concentrations of [3H]dNTP and potential inhibitor being varied as appropriate.
Chain termination. Chain termination studies, which were based on previously published methods (18) , were carried out by the reverse transcription of MS2 RNA by using an oligodeoxynucleotide primer [5 
Enzyme purification. HIV-1 reverse transcriptase (from strain BH10), which was cloned and expressed in Eschenichia coli, was purified as described previously (16) . DNA polymerases alpha, beta, and gamma were purified from HeLa Ohio cells that were grown to the late log phase as monolayers in roller bottles. The different polymerase species were distinguished on the basis of their known biochemical characteristics (10, 23) .
DNA polymerase gamma was partially purified from HeLa Ohio cells by chromatography on Q-Sepharose Fast Flow; this was followed by chromatography on double-stranded DNA cellulose; the conditions used were based on those described previously (14) . The major differences in the procedure from that described previously (14) were that all buffers contained 0.5 mM ?henylmethylsulfonyl fluoride and 10 p,g of pepstatin A ml-, and fractions from the doublestranded DNA cellulose column were collected in tubes containing 0.1 ml of a 15-mg/ml solution of bovine serum albumin, such that its final concentration was approximately 0.6 mg/ml. If bovine serum albumin was not used, much of the polymerase activity was lost. The DNA polymerase gamma activity was eluted at a phosphate buffer concentration of 0.31 to 0.35 M and was totally separated from any residual DNA polymerase alpha activity carried over from the Q-Sepharose column, which was eluted between 0.12 and 0.17 M phosphate buffer. The concentration of phosphate buffer required to elute the DNA polymerase activity from this column was almost identical to that reported previously (14) . This observation, together with the preparations' ability to use poly(rA) -poly(dT)1218 as template and primer in the presence of 50 mM potassium phosphate buffer (pH 7.5) and Km values for dNTPs (see below), was used as evidence that the DNA polymerase activity was that of a gamma polymerase.
DNA polymerase alpha was purified in a manner similar to that described above for DNA polymerase gamma. DNA polymerase alpha-containing fractions from the Q-Sepharose column were further purified on double-stranded DNA cellulose (as above). DNA polymerase alpha activity eluted well separated from residual DNA polymerase gamma activity at a phosphate buffer concentration of about 160 mM. The polymerase alpha activity was 50% inhibited by about 80 mM KCI and was almost totally inhibited by 150 mM KCI. This behavior was expected for DNA polymerase alpha (23) . The polymerase alpha activity was also inhibited by the anti-polymerase alpha antibody SJK-287-38 obtained from CRL 164 cells in an antibody concentration-dependent manner. It has been reported (22) that this antibody is specific for DNA polymerase alpha and does not detectably interact with DNA polymerase beta or gamma.
DNA polymerase beta activity was not retained by the Q-Sepharose column under the conditions described above. Non-Q-Sepharose-bound DNA polymerase activity was further purified by chromatography on P11 cellulose phosphate, and the DNA polymerase beta activity, which is resistant to 5 mM N-ethylmaleimide (see for example, reference 17) and which was eluted from the column by approximately 0.7 M KCl, was further purified by chromatography on singlestranded DNA agarose. All DNA polymerases were stored at -70°C until use.
Kinetic studies. DNA polymerases alpha, beta, and gamma were initially characterized by determination of their Km values for dNTPs by using activated calf thymus DNA as the template and primer and the methods described above. The initial rates of reaction were determined as the slopes of the linear portions of counts per minute-against-time progress plots. Km values for dNTPs were determined from plots of the dNTP concentration/initial rate of reaction against the dNTP concentration.
IC50s were measured at dNTP concentrations that were equal to the Km values. They were normally determined from plots of inhibitor concentration/fraction inhibition against the inhibitor concentration, which were linear over the inhibitor concentration ranges used. The exception to this was the analysis of the data for 3TC 5'-triphosphate with DNA polymerase alpha. As discussed below, such plots were not appropriate for the analysis of these data. IC50s for 3TC 5'-triphosphate with DNA polymerase alpha were, therefore, estimated from the apparently linear portions of plots of the reciprocal of the rate of reaction against the inhibitor concentration. For more detailed kinetic analyses, double-reciprocal plots were constructed for several inhibitor concentrations. Values of K1 were determined from secondary plots of slope against inhibitor concentration. Graphs were generated by using RS1 software (BBN Software Products Corporation, Cambridge, Mass.). RESULTS MS2 RNA and oligoprimer assay. The use of the MS2 RNA assay system enabled us to undertake a direct comparison of the inhibitory effects of all 5'-triphosphates used in this study. Reaction conditions were optimized for this template DNA-dependent DNA polymerase activity. The IC50s determined for the 5' triphosphates of 3TC and the corresponding racemate (BCH 189), ddATP, ddCTP, and AZT 5'-triphosphate, using the appropriate radiolabeled dNTP at a concentration equal to the Ki,, the other three dNTPs at concentrations of >10 times the Ki,, and activated calf thymus DNA as the template and primer are given in Table 1 . With the exception of AZT 5'-triphosphate (which, by an order of magnitude, was a less effective inhibitor of the DNA-dependent DNA polymerase activity than of the RNA-dependent DNA polymerase activity), the IC50s were not very different from the Ki values determined for these compounds when inhibiting the RNA-dependent DNA polymerase activity of the same enzyme.
Mammalian DNA polymerases. DNA polymerases alpha, beta, and gamma were first characterized by determination of their Km values for dNTPs (Table 2) , which were within the ranges reported previously (10, 23, 24 Table 2 .
Chain termination studies. The ability of 3TC 5'-triphosphate to serve as a substrate for HIV-1 reverse transcriptase was examined with primed MS2 RNA as the template and primer (Fig. 2) . Comparison of the primer extension products observed in the presence of ddCTP (Fig. 2, lanes C) and 3TC 5'-triphosphate [ Fig. 2, lane B(-) ] shows that the two triphosphates were incorporated and that chain termination by the two triphosphates occurs in apparently identical ways.
DISCUSSION
The competitive nature (with respect to dCTP) of the inhibition of HIV-1 reverse transcriptase by 3TC 5'-triphosphate and the chain termination that it brings about when it is incorporated in place of dCTP indicate that the mode of action of 3TC as an antiviral agent may be similar to that proposed for ddC (19) . However, the observation that both 3TC 5'-triphosphate and the corresponding (+)-enantiomer inhibit HIV-1 reverse transcriptase is unusual. The (+)-enantiomer, which has a conformation typical of those of natural nucleosides (21) , is more inhibitory than the (-)-enantiomer, but the activity of the (-)-enantiomer, which has an unnatural conformation (21) , is nevertheless remarkable.
The level of inhibition of HIV-1 reverse transcriptase by 3TC 5'-triphosphate, although weaker than that observed for ddCTP and AZT 5'-triphosphate, could be consistent with the hypothesis that the antiviral activity of 3TC is mediated at least in part by inhibition of reverse transcriptase when observations on phosphorylation of the nucleoside analog in human peripheral blood lymphocytes and the antiviral activity of 3TC in infected peripheral blood lymphocytes (6) are considered. Levels of 3TC 5'-triphosphate in cells treated with 10 ,uM 3TC reach 2 to 14 pmol/106 cells (3) . This is comparable to the levels reported for ddCTP (19) and is approximately 10 times that reported for AZT 5'-triphosphate (11) . The half-life of 3TC 5'-triphosphate (10 to 15 h [3] ) is also longer than those reported for ddCTP (2.6 h) and AZT 5'-triphosphate (1 h). The higher levels and longer half-life of 3TC 5'-triphosphate could compensate for the weaker inhibition of reverse transcriptase compared with those of AZT 5'-triphosphate and ddCTP. The half-life of the (+)-enantiomer of 2'-deoxy-3'-thiacytidine 5'-triphosphate is shorter than that of 3TC 5'-triphosphate (3), which may account for the observation that the (+)-enantiomeric 5'-triphosphate is about a sixfold better inhibitor of HIV-1 reverse transcriptase than 3TC 5'-triphosphate is (Table 1) , even though it is only about half as effective against the virus in vitro (7) .
All of the 5'-triphosphates tested in the study described here were weak inhibitors of DNA polymerase alpha ( Table  2 ). The behavior of 3TC 5'-triphosphate with DNA polymerase alpha needs more comment, however. Plots of inhibitor concentration/fraction inhibition against the inhibitor concentration, which were good straight lines with the racemic form and the (+)-enantiomeric form with DNA polymerase alpha and with all inhibitory compounds tested with DNA polymerases beta and gamma, showed no discernible trends in the dependence of the ratio inhibitor concentration/fraction inhibition on the inhibitor concentration. Plots of the reciprocal of the initial rate against the inhibitor concentration were normally curved, with the inhibition at high concentrations of 3TC 5'-triphosphate being greater than that expected from the degree of inhibition at low concentrations. However, at concentrations of 3TC 5'-triphosphate below 120 to 180 ,uM, the plots closely approximated straight lines. IC50s were estimated from these essentially linear portions of the plots.
The inhibition of DNA polymerase alpha by 3TC 5'-triphosphate is complex. Expression of the data in the form of Hill plots shows that, for fraction inhibitions of between 0.1 and 0.9, the plots are linear, with slopes of between 1.86 and 2.17. There would therefore seem to be at least two different types of binding site for 3TC 5'-triphosphate on DNA polymerase alpha. Such complex binding was not apparent, though, for the racemate or the (+)-enantiomer.
The inhibition of DNA polymerase gamma by the 5'-triphosphates used in this study is very different from that found with DNA polymerase alpha. 3TC 5'-triphosphate is a rather weak inhibitor of this enzyme (average IC50, 43.8 ,uM), but the racemic form is about 650 times more inhibitory and the (+)-enantiomer is even more effective. Comparison of the IC50s (Table 2) shows that the effective inhibition of DNA polymerase gamma by the racemic triphosphate is almost entirely due to the (+)-enantiomer. Inhibition of DNA polymerase gamma such as that seen with the racemate and the (+)-enantiomer could lead to considerable cellular toxicity. Cellular toxicity was, in fact, seen when CEM cells were incubated with the corresponding nucleosides (6) , although this toxicity need not necessarily be due or be solely due to inhibition of DNA polymerase gamma. The (-)-enantiomer was significantly less toxic to the cells than was either the racemate or the (+)-enantiomer.
The approximately 1,000 times more effective inhibition of DNA polymerase gamma by the (+)-enantiomer compared with that by the (-)-enantiomer is perhaps not surprising since the configuration of the (+)-enantiomer (21) is the same as that seen in the natural substrates, the dNTPs. This result is in marked contrast, however, to the results observed with HIV-1 reverse transcriptase (see above), in which the inhibition by the (+)-enantiomer was only about six times greater than that by the (-)-enantiomer, and the (-)-enantiomeric nucleoside, like the (+)-enantiomeric nucleoside, is a very effective antiviral compound in cultured HIV-1-infected cells (6) .
There are important differences between the effects of 3TC 5'-triphosphate and ddATP and ddCTP on DNA polymerase gamma. The ddNTPs are nearly 1,000 times more effective than 3TC 5'-triphosphate as inhibitors of this enzyme. If inhibition of DNA polymerase gamma is an event that results in cellular toxicity, then 3TC might be expected to be significantly less toxic than ddC or ddM. ddl has been shown to require intracellular conversion to ddATP in order to be active against HIV-1 (1, 13).
The results obtained with DNA polymerase beta were qualitatively very similar to those obtained with DNA polymerase gamma. 3TC 5'-triphosphate is not a potent inhibitor of DNA polymerase beta (average IC50, 24.8 p,M), whereas the racemic form is significantly more inhibitory. ddATP and ddCTP are also significantly more inhibitory to DNA polymerase beta than is 3TC 5'-triphosphate, although AZT 5'-triphosphate is a poor inhibitor of this enzyme.
The results presented above (Tables 1 and 2 ) seem to be unable to explain two important aspects of the inhibition of HIV-1 by 3TC in cells cultured in vitro. First, the K' values for 3TC 5'-triphosphate are several orders of magnitude greater than the 50% inhibitory doses of 3TC for the virus; i.e., the nucleoside is more effective against the virus than the 5'-triphosphate appears to be against the viral reverse transcriptase. However, an absolute correlation between enzyme inhibition in vitro and the effects in cells need not be expected, since there are many conditions that differ between the assays described here and the conditions in which HIV-1 reverse transcriptase functions in infected cells. The templates and primers used in the study of the effect of 3TC 5'-triphosphate on the DNA polymerase activity of reverse transcriptase, i.e., primed MS2 RNA, activated DNA, and poly(rI)-poly(dC), are, by necessity, artificial and different from those that the enzyme will encounter in HIV-1-infected cells. Different templates and primers will give rise to binary enzyme-template and primer complexes whose interactions with a particular ligand might result in significantly different Ki values. Such an explanation for the observed results with 3TC and its 5'-triphosphate cannot be ruled out, although there is little difference in the inhibition of HIV-1 reverse transcriptase by 3TC 5'-triphosphate in the presence of these different templates.
The second consideration concerns the specificity of 3TC and its 5'-triphosphate. In vitro studies (6) showed that 3TC is a very effective anti-HIV-1 compound, but it shows little toxicity against mammalian cells. Comparison of the K1 values for 3TC 5'-triphosphate against HIV-1 reverse transcriptase with the values obtained for DNA polymerases beta and gamma suggests that 3TC might be as toxic to mammalian cells as it is to HIV-1. This clearly is not the case (6) . The two apparent difficulties are probably reconcilable when the results of the chain termination studies (Fig. 2) Chain termination studies with 3TC 5'-triphosphate and DNA polymerases beta and gamma have not yet been carried out, but even if both of these enzymes are able to incorporate 3TC 5'-monophosphate into DNA, DNA proofreading and repair enzymes may remove the unusual nucleotide. Efficient proofreading of the HIV-1 genome has not yet been demonstrated. Thus, the potency of 3TC against HIV-1 is probably more due to the chain-terminating property of the 5'-triphosphate than to competitive inhibition, and the selectivity is probably due to the lack of exonuclease activity within or associated with HIV-1 reverse transcriptase. Work is in progress to try to obtain evidence for these hypotheses.
